AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2025
Mar 24, 2025
32853_dirs_2025-03-24_3ad05029-0e32-4330-b681-05d5d554a808.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2025-03-21
Reporting Person: Mackay Sean (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-21 | Common Stock | A | 281667 | — | Acquired | 881667 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | Stock Option (Right to Buy) | $1.21 | A | 422500 | Acquired | 2035-03-21 | Common Stock (422500) | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") that vest over four years, with 1/16th of the RSUs vesting on May 20, 2025 and the remaining RSUs vesting in equally quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2: The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2025, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.